LBT Innovations Limited (LBT.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.74 Million AUD | -5.73% |
| 2023 | 3.38 Million AUD | -20.99% |
| 2022 | 4.28 Million AUD | -11.75% |
| 2021 | 4.85 Million AUD | 25.43% |
| 2020 | 3.87 Million AUD | 54.92% |
| 2019 | 2.5 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 1.05 Million AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | -100.0% |
| 2007 | 10 Thousand AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 3.19 Million AUD | -5.73% |
| 2024 Q4 | 1.74 Million AUD | 0.0% |
| 2024 Q2 | 3.29 Million AUD | 0.0% |
| 2023 Q2 | 2.74 Million AUD | 0.0% |
| 2023 FY | 3.38 Million AUD | -20.99% |
| 2023 Q4 | 3.38 Million AUD | 0.0% |
| 2022 Q4 | 4.28 Million AUD | 0.0% |
| 2022 FY | 4.28 Million AUD | -11.75% |
| 2022 Q2 | 3.82 Million AUD | 0.0% |
| 2021 Q4 | 4.85 Million AUD | 0.0% |
| 2021 FY | 4.85 Million AUD | 25.43% |
| 2021 Q2 | 2.46 Million AUD | 0.0% |
| 2020 Q4 | 3.87 Million AUD | 0.0% |
| 2020 FY | 3.87 Million AUD | 54.92% |
| 2020 Q2 | 1.46 Million AUD | 0.0% |
| 2019 FY | 2.5 Million AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | 2.5 Million AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 Q4 | 1.05 Million AUD | 0.0% |
| 2015 FY | 1.05 Million AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | -100.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2007 FY | 10 Thousand AUD | 0.0% |
| 2007 Q4 | 10 Thousand AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 65.961% |
| Adherium Limited | 93.2 Thousand AUD | -1770.071% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 74.431% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -1958.58% |
| Anteris Technologies Ltd | 2.33 Million AUD | 25.286% |
| Control Bionics Limited | 961.73 Thousand AUD | -81.234% |
| CardieX Limited | 3.22 Million AUD | 46.0% |
| Compumedics Limited | 6.97 Million AUD | 75.018% |
| Cochlear Limited | 243.7 Million AUD | 99.285% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 49.424% |
| Cyclopharm Limited | 4.22 Million AUD | 58.768% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 39.903% |
| Nova Eye Medical Limited | 3.34 Million AUD | 47.955% |
| HeraMED Limited | 260.65 Thousand AUD | -568.697% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 88.899% |
| ImpediMed Limited | 1.14 Million AUD | -52.493% |
| InhaleRx Limited | 560.27 Thousand AUD | -211.097% |
| Micro-X Limited | 4.05 Million AUD | 57.016% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -2366.323% |
| PolyNovo Limited | 15.38 Million AUD | 88.667% |
| Respiri Limited | 1.17 Million AUD | -48.143% |
| SomnoMed Limited | 1.01 Million AUD | -71.553% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 64.94% |
| Uscom Limited | 989.27 Thousand AUD | -76.189% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -458.375% |